156 related articles for article (PubMed ID: 35292786)
61. Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility.
Baloch ZW; Abraham S; Roberts S; LiVolsi VA
Hum Pathol; 1999 Oct; 30(10):1166-71. PubMed ID: 10534163
[TBL] [Abstract][Full Text] [Related]
62. Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma.
Salajegheh A; Pakneshan S; Rahman A; Dolan-Evans E; Zhang S; Kwong E; Gopalan V; Lo CY; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2204-12. PubMed ID: 23845470
[TBL] [Abstract][Full Text] [Related]
63. ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome.
Tavares C; Melo M; Cameselle-Teijeiro JM; Soares P; Sobrinho-Simões M
Eur J Endocrinol; 2016 Apr; 174(4):R117-26. PubMed ID: 26510840
[TBL] [Abstract][Full Text] [Related]
64. Factors predictive of lymph node metastasis in the follicular variant of papillary thyroid carcinoma.
Blanchard C; Brient C; Volteau C; Sebag F; Roy M; Drui D; Hamy A; Mathonnet M; Henry JF; Mirallié E
Br J Surg; 2013 Sep; 100(10):1312-7. PubMed ID: 23939843
[TBL] [Abstract][Full Text] [Related]
65. Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours.
Kotani T; Asada Y; Aratake Y; Umeki K; Yamamoto I; Tokudome R; Hirai K; Kuma K; Konoe K; Araki Y
J Pathol; 1992 Sep; 168(1):41-5. PubMed ID: 1360496
[TBL] [Abstract][Full Text] [Related]
66. Increasing diagnosis of thyroid papillary carcinoma follicular variant in south-east Anatolian region: comparison of characteristics of classical papillary and follicular variant thyroid cancers.
Ertek S; Yılmaz NC; Cicero AF; Vurupalmaz Ö; Demiröz AS; Erdoğan G
Endocr Pathol; 2012 Sep; 23(3):157-60. PubMed ID: 22711546
[TBL] [Abstract][Full Text] [Related]
67. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma.
Dobashi Y; Sakamoto A; Sugimura H; Mernyei M; Mori M; Oyama T; Machinami R
Am J Surg Pathol; 1993 Apr; 17(4):375-81. PubMed ID: 7684202
[TBL] [Abstract][Full Text] [Related]
68. Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features in Children: An Institutional Experience and Literature Review.
Wang H; Correa H; Sanders M; Neblett WW; Liang J
Pediatr Dev Pathol; 2020; 23(2):121-126. PubMed ID: 31483741
[TBL] [Abstract][Full Text] [Related]
69. The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer.
Eberhardt NL; Grebe SK; McIver B; Reddi HV
Mol Cell Endocrinol; 2010 May; 321(1):50-6. PubMed ID: 19883731
[TBL] [Abstract][Full Text] [Related]
70. Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma.
Marečko I; Cvejić D; Tatić S; Dragutinović V; Paunović I; Savin S
Cancer Biomark; 2011-2012; 11(1):49-58. PubMed ID: 22820140
[TBL] [Abstract][Full Text] [Related]
71. A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.
Castro P; Roque L; Magalhães J; Sobrinho-Simões M
Int J Surg Pathol; 2005 Jul; 13(3):235-8. PubMed ID: 16086077
[TBL] [Abstract][Full Text] [Related]
72. Spindle Cell/Sclerosing Rhabdomyosarcoma With
Rakheja D; Park JY; Alhasan M; Uddin N
Int J Surg Pathol; 2022 Dec; 30(8):950-955. PubMed ID: 35466752
[TBL] [Abstract][Full Text] [Related]
73. Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features.
Fu G; Polyakova O; MacMillan C; Ralhan R; Walfish PG
EBioMedicine; 2017 Apr; 18():50-55. PubMed ID: 28363612
[TBL] [Abstract][Full Text] [Related]
74. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
[TBL] [Abstract][Full Text] [Related]
75. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
Wang T; Jiang CX; Li Y; Liu X
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
[TBL] [Abstract][Full Text] [Related]
76. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.
Wreesmann VB; Ghossein RA; Hezel M; Banerjee D; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B
Genes Chromosomes Cancer; 2004 Aug; 40(4):355-64. PubMed ID: 15188460
[TBL] [Abstract][Full Text] [Related]
77. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.
Pesutić-Pisac V; Punda A; Gluncić I; Bedeković V; Pranić-Kragić A; Kunac N
Croat Med J; 2008 Oct; 49(5):643-9. PubMed ID: 18925698
[TBL] [Abstract][Full Text] [Related]
78. Molecular pathology of well-differentiated thyroid carcinomas.
Sobrinho-Simões M; Preto A; Rocha AS; Castro P; Máximo V; Fonseca E; Soares P
Virchows Arch; 2005 Nov; 447(5):787-93. PubMed ID: 16189702
[TBL] [Abstract][Full Text] [Related]
79. Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.
Fisher KE; Jani JC; Fisher SB; Foulks C; Hill CE; Weber CJ; Cohen C; Sharma J
J Surg Res; 2013 Nov; 185(1):217-24. PubMed ID: 23746767
[TBL] [Abstract][Full Text] [Related]
80. Papillary thyroid carcinoma variants.
Lloyd RV; Buehler D; Khanafshar E
Head Neck Pathol; 2011 Mar; 5(1):51-6. PubMed ID: 21221869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]